GLP1R and chronic obstructive pulmonary disease: The GLP-1 receptor agonist was found to be effective in decreasing the mortality of COPD female mice, suggesting that the GLP-1 receptor agonist is a promising agent for COPD therapy (Viby et al., 2013).